Neuberger Berman Group LLC Innoviva, Inc. Call Options Transaction History
Neuberger Berman Group LLC
- $124 Billion
- Q2 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding INVA
# of Institutions
288Shares Held
80.3MCall Options Held
10.3KPut Options Held
161K-
Black Rock Inc. New York, NY9.63MShares$173 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.18MShares$129 Million0.0% of portfolio
-
Putnam Investments LLC Boston, MA6.27MShares$113 Million0.14% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny4.76MShares$85.5 Million0.14% of portfolio
-
Dimensional Fund Advisors LP Austin, TX4.29MShares$77.1 Million0.02% of portfolio
About Innoviva, Inc.
- Ticker INVA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 69,706,000
- Market Cap $1.25B
- Description
- Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...